Hims & Hers Health (HIMS) Total Liabilities (2019 - 2026)
Hims & Hers Health (HIMS) posted Total Liabilities of $1.8 billion for Q1 2026, up 12.83% sequentially from $1.6 billion in Q4 2025, and up 431.72% YoY from $342.4 million in Q1 2025.
Hims & Hers Health (HIMS) Total Liabilities (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Total Liabilities for 8 years, with the latest figure at $1.8 billion in Q1 2026.
- Quarterly Total Liabilities rose 431.72% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 431.72% YoY) and the FY2025 annual result came in at $1.6 billion, up 599.14% from the prior year.
- Total Liabilities rose to $1.8 billion in Q1 2026 per HIMS's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $1.8 billion in Q1 2026 and troughed at $54.3 million in Q1 2022.
- A 5-year average of $465.7 million and a median of $103.6 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities plunged 36.49% in 2022, then soared 1009.29% in 2025.
- Over 5 years, Total Liabilities stood at $54.6 million in 2022, then jumped by 77.94% to $97.2 million in 2023, then soared by 137.58% to $230.8 million in 2024, then soared by 599.14% to $1.6 billion in 2025, then increased by 12.83% to $1.8 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $1.8 billion, $1.6 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 32.27 Bn | 30.60 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.33 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.93 Bn | 18.04 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Hims & Hers Health | 7.84 Bn | 7.00 Bn | 480.80 Mn | 3.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.30 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 342.45 Mn |
| Dec 31, 2024 | 230.82 Mn |
| Sep 30, 2024 | 162.21 Mn |
| Jun 30, 2024 | 118.53 Mn |
| Mar 31, 2024 | 103.62 Mn |
| Dec 31, 2023 | 97.16 Mn |
| Sep 30, 2023 | 85.30 Mn |
| Jun 30, 2023 | 69.81 Mn |
| Mar 31, 2023 | 63.56 Mn |
| Dec 31, 2022 | 54.60 Mn |
| Sep 30, 2022 | 71.88 Mn |
| Jun 30, 2022 | 60.91 Mn |
| Mar 31, 2022 | 54.32 Mn |
| Dec 31, 2021 | 85.97 Mn |
| Sep 30, 2021 | 64.92 Mn |